|
Symbol
|
RMBQ5V | KZEHDU | KZJVDU | RMBAIV | LAAHDU | Z0B18Z | RMA09V | RMBX5V | ACMVSQ | ADAATQ | RMAY9V | RMBACV | ADXETQ | DAGBKB | LAUJDU | 1129BC | AEEBTQ | AEACTQ | ADAGSQ | AENOTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Underlying
|
Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novo Nordisk AS (B) / Roche PS | Amazon.com Inc. / Novo Nordisk AS (B) / UBS Group AG | Novo Nordisk AS (B) / Philips Electronics N.V. / Roche PS / Siemens Healthineers | Novo Nordisk AS (B) / SAP SE | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novartis AG / Novo Nordisk AS (B) / Roche PS / Sanofi S.A. | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Bayer AG / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Bayer AG / Eli Lilly & Co. / Novo Nordisk AS (B) | Bayer AG / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly & Co. / Novo Nordisk AS (B) |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
17.11.2026 | 20.11.2026 | 30.12.2026 | 30.12.2026 | 28.10.2026 | 29.10.2026 | 12.05.2027 | 16.11.2026 | 23.11.2026 | 27.11.2026 | 14.01.2027 | 25.01.2027 | 12.02.2027 | 12.02.2027 | 01.03.2027 | 05.03.2027 | 08.12.2026 | 16.03.2027 | 22.12.2026 | 07.04.2027 |
| Bid | 35.630 | 34.550 | 32.750 | 44.400 | - | - | 61.78 | 60.60 | 63.67 | 60.73 | 58.70 | 91.52 | 101.28 | 102.85 | 97.80 | 92.81 | 95.94 | 95.78 | 98.87 | 91.86 |
| Ask | - | 35.550 | - | - | - | - | - | - | - | - | - | - | 102.09 | 103.68 | 98.80 | 93.55 | - | 96.58 | 99.67 | 92.66 |